| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_92ebee933d7b49d9a67bd55f31ce03c0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2220-0016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2220-0008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2210-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2210-0004 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00772
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0017 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007 |
| filingDate |
2016-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c01467880eb27d74f889652f63f2a911
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad442f5b61d9e81784b14b6f95225465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd972b64ccd2b84bb8538426d788e6df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e4dca37186e0c5207befd4cbcc295d0 |
| publicationDate |
2017-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2017053885-A1 |
| titleOfInvention |
Punctal implants with controlled drug delivery features and methods of using same |
| abstract |
Disclosed herein are drug delivery punctal implants and methods of using the implants for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The physical arrangement of drugs within the punctal plugs disclosed herein results, in several embodiments, in advantageous controlled deliver}' of one or more drugs to the eye of a patient. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10206813-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10245178-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11019997-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10959941-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11019996-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10406029-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11116625-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11318043-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11253394-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11426306-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11376040-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11564833-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020011215-A1 |
| priorityDate |
2015-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |